Metraipolis › archive › dc_5033a784c85e
The microbiome as a therapeutic co-driver in melanoma immuno-oncology — Europe PMC PMID:41030253
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41030253
- DOI
- 10.3389/fmed.2025.1673880
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T23:15:48.854Z
- SHA-256 of the archived text
ba419758947e9168d32c9c9576a9376ebaf472351dccf30d17341cec59e6076c- Stable URL of this page
https://metraipolis.com/documento/dc_5033a784c85e
How to cite
The microbiome as a therapeutic co-driver in melanoma immuno-oncology — Europe PMC PMID:41030253 — Europe PMC (en), https://europepmc.org/article/MED/41030253 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5033a784c85e (Metraipolis archive dc_5033a784c85e, sha256 ba419758947e9168d32c9c9576a9376ebaf472351dccf30d17341cec59e6076c)
BibTeX
@misc{dc5033a784c85e,
title = {The microbiome as a therapeutic co-driver in melanoma immuno-oncology — Europe PMC PMID:41030253},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41030253},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5033a784c85e; sha256 ba419758947e9168d32c9c9576a9376ebaf472351dccf30d17341cec59e6076c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41030253. Agents can read the archived copy with the MCP tool read_document.